Observed efficacy of subcutaneous tanezumab or oral nonsteroidal anti-inflammatory drugs in patients with osteoarthritis: subgroup analyses of a phase 3 study. (April 2021) - Hunter, D.J; Radominski, S.; Ulloa, S. Rodriguez; Goranov, I.; Radunovic, G.; Chang, C.; Pixton, G.; Hickman, A.; Fountaine, R.J.; Brown, M.T.; Viktrup, L.; West, C.